Rational use of systematic postoperative CT scans after neurosurgical craniotomy.


Journal

Journal of neurosurgical sciences
ISSN: 1827-1855
Titre abrégé: J Neurosurg Sci
Pays: Italy
ID NLM: 0432557

Informations de publication

Date de publication:
Aug 2020
Historique:
pubmed: 30 9 2017
medline: 5 6 2021
entrez: 30 9 2017
Statut: ppublish

Résumé

The aim of this retrospective study was to evaluate the relevance of a systematic postoperative CT scan after neurosurgical craniotomy and to identify predictive factors of complications. This retrospective analysis included all the patients at our institution who benefited from a cerebral postoperative CT scan within 24 hours post-craniotomy. Patient characteristics and neuroimaging abnormalities were recorded. Predictive factors were identified using a recursive partitioning analysis. A total of 633 patients were included. Of these, 17.9% of patients suffered from postoperative complications and 7.4% of them required a new surgery. The decision for reoperation was based on the neurological deterioration and the CT scan, but never on the CT scan alone. The mortality rate was 1.1%. The risk to be reoperated was correlated to the occurrence of a new postoperative neurological deficit (P<0.001, HR=4.60) and in situ hemorrhage (P<0.001, HR=4.19). The risk of postoperative hematoma was correlated to the supratentorial location versus infratentorial (P=0.027, HR=2.50). With clinical factors, such as location and etiology of the lesion, schedule type of surgery, and the age of patients, we proposed six classes with the risk to present with hemorrhage or midline shift on postoperative CT scans. The post-craniotomy CT scan did not impact patient management as an independent decisional tool. We identified several variables associated with the risk of clinical modification that can impact the decision to reoperate and allow establishment of a risk score. This score could be an interesting tool in order to reduce the systematic use of CT scans in the post-surgical period but has to be validated in a prospective study.

Sections du résumé

BACKGROUND BACKGROUND
The aim of this retrospective study was to evaluate the relevance of a systematic postoperative CT scan after neurosurgical craniotomy and to identify predictive factors of complications.
METHODS METHODS
This retrospective analysis included all the patients at our institution who benefited from a cerebral postoperative CT scan within 24 hours post-craniotomy. Patient characteristics and neuroimaging abnormalities were recorded. Predictive factors were identified using a recursive partitioning analysis.
RESULTS RESULTS
A total of 633 patients were included. Of these, 17.9% of patients suffered from postoperative complications and 7.4% of them required a new surgery. The decision for reoperation was based on the neurological deterioration and the CT scan, but never on the CT scan alone. The mortality rate was 1.1%. The risk to be reoperated was correlated to the occurrence of a new postoperative neurological deficit (P<0.001, HR=4.60) and in situ hemorrhage (P<0.001, HR=4.19). The risk of postoperative hematoma was correlated to the supratentorial location versus infratentorial (P=0.027, HR=2.50). With clinical factors, such as location and etiology of the lesion, schedule type of surgery, and the age of patients, we proposed six classes with the risk to present with hemorrhage or midline shift on postoperative CT scans.
CONCLUSIONS CONCLUSIONS
The post-craniotomy CT scan did not impact patient management as an independent decisional tool. We identified several variables associated with the risk of clinical modification that can impact the decision to reoperate and allow establishment of a risk score. This score could be an interesting tool in order to reduce the systematic use of CT scans in the post-surgical period but has to be validated in a prospective study.

Identifiants

pubmed: 28959872
pii: S0390-5616.17.04082-6
doi: 10.23736/S0390-5616.17.04082-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

335-340

Auteurs

Sébastien Boissonneau (S)

Department of Neurosurgery, La Timone University Hospital, Assistance Publique - Hôpitaux de Marseille (APHM), Marseille, France - sebastien.boissonneau@ap-hm.fr.

Émeline Tabouret (É)

Department of Neuro-Oncology, La Timone University Hospital, Assistance Publique - Hôpitaux de Marseille (APHM), Marseille, France.
INSERM Unit of Research UMR S911, Biologic Oncology and Oncologic Pharmacology Research Center (CRO2), Faculty of Medical and Paramedical Sciences, Aix-Marseille University, Marseille, France.

Thomas Graillon (T)

Department of Neurosurgery, La Timone University Hospital, Assistance Publique - Hôpitaux de Marseille (APHM), Marseille, France.
Center for Research in Neurobiology and Neurophysiology of Marseille (CRN2M), National Center of Scientific Research (CNRS), Aix-Marseille University, Marseille, France.

Mikael Meyer (M)

Department of Neurosurgery, La Timone University Hospital, Assistance Publique - Hôpitaux de Marseille (APHM), Marseille, France.

Lionel Velly (L)

Department of Anesthesiology and Intensive Care, La Timone University Hospital, Assistance Publique - Hôpitaux de Marseille (APHM), Marseille, France.

Nadine Girard (N)

Service of Neuroradiology, La Timone University Hospital, Assistance Publique - Hôpitaux de Marseille (APHM), Marseille, France.

Hervé Brunel (H)

Service of Neuroradiology, La Timone University Hospital, Assistance Publique - Hôpitaux de Marseille (APHM), Marseille, France.

Nicolas Bruder (N)

Department of Anesthesiology and Intensive Care, La Timone University Hospital, Assistance Publique - Hôpitaux de Marseille (APHM), Marseille, France.

Stéphane Fuentes (S)

Department of Neurosurgery, La Timone University Hospital, Assistance Publique - Hôpitaux de Marseille (APHM), Marseille, France.

Henry Dufour (H)

Department of Neurosurgery, La Timone University Hospital, Assistance Publique - Hôpitaux de Marseille (APHM), Marseille, France.
Center for Research in Neurobiology and Neurophysiology of Marseille (CRN2M), National Center of Scientific Research (CNRS), Aix-Marseille University, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH